O	O	O	0	9	Histamine	Histamine	B-NP	NN	O	2	SUB	O
O	O	O	10	19	modulates	modulate	B-VP	VBZ	O	0	ROOT	O
O	O	O	20	23	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	24	34	expression	expression	I-NP	NN	O	2	OBJ	O
O	O	O	35	37	of	of	B-PP	IN	O	4	NMOD	O
T1	B-Protein	B-Protein	38	39	c	c	B-NP	NN	B-DNA	8	NMOD	B-DNA
T1	I-Protein	I-Protein	39	40	-	-	I-NP	HYPH	I-DNA	8	NMOD	I-DNA
T1	I-Protein	I-Protein	40	43	fos	fos	I-NP	NN	I-DNA	5	PMOD	I-DNA
O	O	O	44	51	through	through	B-PP	IN	O	2	VMOD	O
T16	B-Entity	B-Entity	52	58	cyclic	cyclic	B-NP	JJ	O	12	NMOD	O
T16	I-Entity	I-Entity	59	62	AMP	AMP	I-NP	NN	O	12	NMOD	O
O	O	O	63	73	production	production	I-NP	NN	O	9	PMOD	O
O	O	O	74	77	via	via	B-PP	IN	O	12	NMOD	O
O	O	O	78	81	the	the	B-NP	DT	O	16	NMOD	O
T2	B-Protein	B-Protein	82	84	H2	H2	I-NP	NN	B-protein	16	NMOD	B-protein
T2	I-Protein	I-Protein	85	93	receptor	receptor	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	94	96	in	in	B-PP	IN	O	12	NMOD	O
O	O	O	97	100	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	101	106	human	human	I-NP	JJ	B-cell_line	23	NMOD	B-cell_line
O	O	O	107	119	promonocytic	promonocytic	I-NP	JJ	I-cell_line	23	NMOD	I-cell_line
O	O	O	120	124	cell	cell	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	O	125	129	line	line	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	O	130	134	U937	U937	I-NP	NN	I-cell_line	17	PMOD	I-cell_line
O	O	O	134	135	.	.	O	.	O	2	P	O

O	O	O	137	139	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	140	148	examined	examine	B-VP	VBD	O	0	ROOT	O
O	O	O	149	152	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	153	160	effects	effect	I-NP	NNS	O	2	OBJ	O
O	O	O	161	163	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	164	173	histamine	histamine	B-NP	NN	O	9	NMOD	O
O	O	O	174	177	and	and	O	CC	O	9	NMOD	O
O	O	O	178	181	its	its	B-NP	PRP$	O	9	NMOD	O
O	O	O	182	190	agonists	agonist	I-NP	NNS	O	5	PMOD	O
O	O	O	191	193	on	on	B-PP	IN	O	4	NMOD	O
O	O	O	194	197	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	198	208	expression	expression	I-NP	NN	O	10	PMOD	O
O	O	O	209	211	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	212	215	the	the	B-NP	DT	O	17	NMOD	O
T3	B-Protein	B-Protein	216	217	c	c	I-NP	NN	B-DNA	17	NMOD	B-DNA
T3	I-Protein	I-Protein	217	218	-	-	B-NP	HYPH	I-DNA	17	NMOD	I-DNA
T3	I-Protein	I-Protein	218	221	fos	fos	I-NP	NN	I-DNA	21	NMOD	I-DNA
O	O	O	222	225	and	and	I-NP	CC	O	21	NMOD	O
T4	B-Protein	B-Protein	226	227	c	c	I-NP	NN	B-DNA	21	NMOD	B-DNA
T4	I-Protein	I-Protein	227	228	-	-	B-NP	HYPH	I-DNA	21	NMOD	I-DNA
T4	I-Protein	I-Protein	228	231	myc	myc	I-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	O	232	237	proto	proto	B-NP	AFX	O	24	NMOD	O
O	O	O	237	238	-	-	I-NP	HYPH	B-DNA	24	NMOD	B-DNA
O	O	O	238	247	oncogenes	oncogene	B-NP	NNS	I-DNA	21	NMOD	I-DNA
O	O	O	248	250	at	at	B-PP	IN	O	12	NMOD	O
O	O	O	251	254	the	the	B-NP	DT	O	30	NMOD	O
O	O	O	255	270	transcriptional	transcriptional	I-NP	JJ	O	30	NMOD	O
O	O	O	271	274	and	and	I-NP	CC	O	30	NMOD	O
O	O	O	275	288	translational	translational	I-NP	JJ	O	30	NMOD	O
O	O	O	289	295	levels	level	I-NP	NNS	O	25	PMOD	O
O	O	O	296	298	in	in	B-PP	IN	O	12	NMOD	O
O	O	O	299	302	the	the	B-NP	DT	O	37	NMOD	O
O	O	O	303	308	human	human	I-NP	JJ	B-cell_line	37	NMOD	B-cell_line
O	O	O	309	321	promonocytic	promonocytic	I-NP	JJ	I-cell_line	37	NMOD	I-cell_line
O	O	O	322	326	U937	U937	I-NP	NN	I-cell_line	37	NMOD	I-cell_line
O	O	O	327	331	cell	cell	I-NP	NN	I-cell_line	37	NMOD	I-cell_line
O	O	O	332	336	line	line	I-NP	NN	I-cell_line	31	PMOD	I-cell_line
O	O	O	336	337	.	.	O	.	O	2	P	O

O	O	O	338	347	Histamine	Histamine	B-NP	NN	O	3	SUB	O
O	O	O	348	359	transiently	transiently	B-ADVP	RB	O	3	VMOD	O
O	O	O	360	369	increased	increase	B-VP	VBD	O	0	ROOT	O
T17	B-Entity	B-Entity	370	374	cAMP	cAMP	B-NP	NN	O	9	NMOD	O
O	O	O	375	378	and	and	I-NP	CC	O	9	NMOD	O
T5	B-Protein	B-Protein	379	380	c	c	I-NP	NN	O	9	NMOD	O
T5	I-Protein	I-Protein	380	381	-	-	B-NP	HYPH	O	9	NMOD	O
T5	I-Protein	I-Protein	381	384	fos	fos	I-NP	NN	O	9	NMOD	O
O	O	O	385	395	expression	expression	I-NP	NN	O	3	OBJ	O
O	O	O	396	403	through	through	B-PP	IN	O	3	VMOD	O
T6	B-Protein	B-Protein	404	406	H2	H2	B-NP	NN	B-protein	12	NMOD	B-protein
T6	I-Protein	I-Protein	407	416	receptors	receptor	I-NP	NNS	I-protein	10	PMOD	I-protein
O	O	O	416	417	.	.	O	.	O	3	P	O

T18	B-Entity	B-Entity	418	427	Dibutyryl	Dibutyryl	B-NP	NN	O	2	NMOD	O
T18	I-Entity	I-Entity	428	432	cAMP	cAMP	I-NP	NN	O	4	SUB	O
O	O	O	433	437	also	also	B-ADVP	RB	O	4	VMOD	O
O	O	O	438	447	increased	increase	B-VP	VBD	O	14	VMOD	O
T7	B-Protein	B-Protein	448	449	c	c	B-NP	NN	B-RNA	10	NMOD	B-RNA
T7	I-Protein	I-Protein	449	450	-	-	I-NP	HYPH	I-RNA	10	NMOD	I-RNA
T7	I-Protein	I-Protein	450	453	fos	fos	I-NP	NN	I-RNA	8	NMOD	I-RNA
O	O	O	454	458	mRNA	mRNA	I-NP	NN	I-RNA	10	NMOD	I-RNA
O	O	O	459	462	and	and	I-NP	CC	O	10	NMOD	O
O	O	O	463	470	protein	protein	I-NP	NN	O	4	OBJ	O
O	O	O	470	471	,	,	O	,	O	14	P	O
O	O	O	472	475	and	and	O	CC	O	14	VMOD	O
O	O	O	476	482	levels	level	B-NP	NNS	O	14	SUB	O
O	O	O	483	491	remained	remain	B-VP	VBD	O	0	ROOT	O
O	O	O	492	500	elevated	elevate	I-VP	VBN	O	14	PRD	O
O	O	O	501	505	even	even	B-ADVP	RB	O	17	PMOD	O
O	O	O	506	511	after	after	B-PP	IN	O	15	AMOD	O
O	O	O	512	514	12	12	B-NP	CD	O	19	NMOD	O
O	O	O	515	517	hr	hr	I-NP	NN	O	17	PMOD	O
O	O	O	518	520	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	521	530	treatment	treatment	B-NP	NN	O	20	PMOD	O
O	O	O	530	531	.	.	O	.	O	14	P	O

O	O	O	532	536	Dose	Dose	B-NP	NN	O	4	NMOD	O
O	O	O	536	537	-	-	I-NP	HYPH	O	4	NMOD	O
O	O	O	537	547	dependence	dependence	I-NP	NN	O	4	NMOD	O
O	O	O	548	555	studies	study	I-NP	NNS	O	9	SUB	O
O	O	O	556	561	using	use	B-VP	VBG	O	4	NMOD	O
O	O	O	562	571	histamine	histamine	B-NP	NN	O	8	NMOD	O
O	O	O	572	575	and	and	I-NP	CC	O	8	NMOD	O
O	O	O	576	584	dimaprit	dimaprit	I-NP	NN	O	5	OBJ	O
O	O	O	585	591	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	592	596	that	that	B-SBAR	IN	O	9	VMOD	O
O	O	O	597	600	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	601	605	EC50	EC50	I-NP	NN	O	13	NMOD	O
O	O	O	606	612	values	value	I-NP	NNS	O	22	SUB	O
O	O	O	613	616	for	for	B-PP	IN	O	13	NMOD	O
T19	B-Entity	B-Entity	617	621	cAMP	cAMP	B-NP	NN	O	16	NMOD	O
O	O	O	622	632	production	production	I-NP	NN	O	21	NMOD	O
O	O	O	633	636	and	and	I-NP	CC	O	21	NMOD	O
T8	B-Protein	B-Protein	637	638	c	c	I-NP	NN	O	21	NMOD	O
T8	I-Protein	I-Protein	638	639	-	-	B-NP	HYPH	O	21	NMOD	O
T8	I-Protein	I-Protein	639	642	fos	fos	I-NP	NN	O	21	NMOD	O
O	O	O	643	651	increase	increase	I-NP	NN	O	14	PMOD	O
O	O	O	652	656	were	be	B-VP	VBD	O	10	SBAR	O
O	O	O	657	664	similar	similar	B-ADJP	JJ	O	22	PRD	O
O	O	O	664	665	,	,	O	,	O	9	P	O
O	O	O	666	676	suggesting	suggest	B-VP	VBG	O	9	VMOD	O
O	O	O	677	681	that	that	B-SBAR	IN	O	25	VMOD	O
T20	B-Entity	B-Entity	682	686	cAMP	cAMP	B-NP	NN	O	28	SUB	O
O	O	O	687	692	might	might	B-VP	MD	O	26	SBAR	O
O	O	O	693	695	be	be	I-VP	VB	O	28	VC	O
O	O	O	696	704	involved	involve	I-VP	VBN	O	29	VC	O
O	O	O	705	707	in	in	B-PP	IN	O	30	VMOD	O
T9	B-Protein	B-Protein	708	709	c	c	B-NP	NN	B-DNA	35	NMOD	B-DNA
T9	I-Protein	I-Protein	709	710	-	-	I-NP	HYPH	I-DNA	35	NMOD	I-DNA
T9	I-Protein	I-Protein	710	713	fos	fos	I-NP	NN	I-DNA	35	NMOD	I-DNA
O	O	O	714	723	induction	induction	I-NP	NN	O	31	PMOD	O
O	O	O	724	727	via	via	B-PP	IN	O	35	NMOD	O
T10	B-Protein	B-Protein	728	730	H2	H2	B-NP	NN	B-protein	38	NMOD	B-protein
T10	I-Protein	I-Protein	731	740	receptors	receptor	I-NP	NNS	I-protein	36	PMOD	I-protein
O	O	O	740	741	.	.	O	.	O	9	P	O

O	O	O	742	753	Furthermore	Furthermore	B-ADVP	RB	O	19	VMOD	O
O	O	O	753	754	,	,	O	,	O	19	P	O
O	O	O	755	762	studies	study	B-NP	NNS	O	19	SUB	O
O	O	O	763	770	carried	carry	B-VP	VBD	O	3	NMOD	O
O	O	O	771	774	out	out	B-PRT	RP	O	4	VMOD	O
O	O	O	775	780	using	use	B-VP	VBG	O	4	VMOD	O
O	O	O	781	783	H7	H7	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	O	783	784	,	,	O	,	O	17	P	O
O	O	O	785	786	a	a	B-NP	DT	O	17	NMOD	O
O	O	O	787	794	protein	protein	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	795	801	kinase	kinase	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	802	803	A	A	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	803	804	/	/	B-VP	SYM	O	17	P	O
O	O	O	804	811	protein	protein	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	O	812	818	kinase	kinase	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	819	820	C	C	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	821	830	inhibitor	inhibitor	I-NP	NN	O	6	OBJ	O
O	O	O	830	831	,	,	O	,	O	3	P	O
O	O	O	832	839	blocked	block	B-VP	VBD	O	0	ROOT	O
T11	B-Protein	B-Protein	840	841	c	c	B-NP	NN	B-DNA	23	NMOD	B-DNA
T11	I-Protein	I-Protein	841	842	-	-	I-NP	HYPH	I-DNA	23	NMOD	I-DNA
T11	I-Protein	I-Protein	842	845	fos	fos	I-NP	NN	I-DNA	23	NMOD	I-DNA
O	O	O	846	855	induction	induction	I-NP	NN	O	19	OBJ	O
O	O	O	855	856	,	,	O	,	O	19	P	O
O	O	O	857	864	whereas	whereas	O	IN	O	19	VMOD	O
O	O	O	865	867	no	no	B-NP	DT	O	27	NMOD	O
O	O	O	868	874	effect	effect	I-NP	NN	O	28	SUB	O
O	O	O	875	878	was	be	B-VP	VBD	O	25	SBAR	O
O	O	O	879	887	observed	observe	I-VP	VBN	O	28	VC	O
O	O	O	888	892	with	with	B-PP	IN	O	29	VMOD	O
O	O	O	893	912	bisindolylmaleimide	bisindolylmaleimide	B-NP	NN	O	38	NMOD	O
O	O	O	912	913	,	,	O	,	O	38	P	O
O	O	O	914	915	a	a	B-NP	DT	O	38	NMOD	O
O	O	O	916	924	specific	specific	I-NP	JJ	O	38	NMOD	O
O	O	O	925	932	protein	protein	I-NP	NN	B-protein	38	NMOD	B-protein
O	O	O	933	939	kinase	kinase	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	O	940	941	C	C	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	O	942	951	inhibitor	inhibitor	I-NP	NN	O	30	PMOD	O
O	O	O	951	952	.	.	O	.	O	19	P	O

O	O	O	953	955	No	No	B-NP	DT	O	2	NMOD	O
O	O	O	956	968	modification	modification	I-NP	NN	O	8	SUB	O
O	O	O	969	971	of	of	B-PP	IN	O	2	NMOD	O
T12	B-Protein	B-Protein	972	973	c	c	B-NP	NN	B-DNA	7	NMOD	B-DNA
T12	I-Protein	I-Protein	973	974	-	-	O	HYPH	I-DNA	7	NMOD	I-DNA
T12	I-Protein	I-Protein	974	977	myc	myc	B-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	O	978	988	expression	expression	I-NP	NN	O	3	PMOD	O
O	O	O	989	994	could	could	B-VP	MD	O	0	ROOT	O
O	O	O	995	997	be	be	I-VP	VB	O	8	VC	O
O	O	O	998	1006	detected	detect	I-VP	VBN	O	9	VC	O
O	O	O	1007	1009	on	on	B-PP	IN	O	10	VMOD	O
O	O	O	1010	1019	treatment	treatment	B-NP	NN	O	11	PMOD	O
O	O	O	1020	1024	with	with	B-PP	IN	O	12	NMOD	O
O	O	O	1025	1034	histamine	histamine	B-NP	NN	O	17	NMOD	O
O	O	O	1035	1037	or	or	O	CC	O	17	NMOD	O
O	O	O	1038	1041	its	its	B-NP	PRP$	O	17	NMOD	O
O	O	O	1042	1051	analogues	analogue	I-NP	NNS	O	13	PMOD	O
O	O	O	1051	1052	.	.	O	.	O	8	P	O

O	O	O	1053	1065	Nevertheless	Nevertheless	B-ADVP	RB	O	5	VMOD	O
O	O	O	1065	1066	,	,	O	,	O	5	P	O
T21	B-Entity	B-Entity	1067	1076	dibutyryl	dibutyryl	B-NP	NN	O	4	NMOD	O
T21	I-Entity	I-Entity	1077	1081	cAMP	cAMP	I-NP	NN	O	5	SUB	O
O	O	O	1082	1089	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	O	1090	1091	a	a	B-NP	DT	O	9	NMOD	O
O	O	O	1092	1096	down	down	I-NP	RB	O	8	AMOD	O
O	O	O	1096	1097	-	-	I-NP	HYPH	O	9	NMOD	O
O	O	O	1097	1107	regulation	regulation	I-NP	NN	O	5	OBJ	O
O	O	O	1108	1110	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	1111	1114	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	1115	1121	levels	level	I-NP	NNS	O	10	PMOD	O
O	O	O	1122	1124	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	1125	1129	this	this	B-NP	DT	O	17	NMOD	O
T22	B-Entity	B-Entity	1130	1135	proto	proto	I-NP	AFX	B-DNA	17	NMOD	B-DNA
T22	I-Entity	I-Entity	1135	1136	-	-	I-NP	HYPH	I-DNA	17	NMOD	I-DNA
T22	I-Entity	I-Entity	1136	1144	oncogene	oncogene	I-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	O	1144	1145	.	.	O	.	O	5	P	O

O	O	O	1146	1148	In	In	B-PP	IN	O	6	VMOD	O
O	O	O	1149	1157	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	1157	1158	,	,	O	,	O	6	P	O
T23	B-Entity	B-Entity	1159	1168	dibutyryl	dibutyryl	B-NP	NN	O	5	NMOD	O
T23	I-Entity	I-Entity	1169	1173	cAMP	cAMP	I-NP	NN	O	6	SUB	O
O	O	O	1174	1183	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	O	1184	1188	cell	cell	B-NP	NN	O	8	NMOD	O
O	O	O	1189	1195	growth	growth	I-NP	NN	O	6	OBJ	O
O	O	O	1196	1198	in	in	B-PP	IN	O	6	VMOD	O
O	O	O	1199	1200	a	a	B-NP	DT	O	14	NMOD	O
O	O	O	1201	1205	dose	dose	I-NP	NN	O	14	NMOD	O
O	O	O	1205	1206	-	-	B-NP	HYPH	O	14	NMOD	O
O	O	O	1206	1215	dependent	dependent	I-NP	JJ	O	14	NMOD	O
O	O	O	1216	1222	manner	manner	I-NP	NN	O	9	PMOD	O
O	O	O	1222	1223	,	,	O	,	O	6	P	O
O	O	O	1224	1231	whereas	whereas	O	IN	O	6	VMOD	O
O	O	O	1232	1241	histamine	histamine	B-NP	NN	O	18	SUB	O
O	O	O	1242	1248	failed	fail	B-VP	VBD	O	16	SBAR	O
O	O	O	1249	1251	to	to	I-VP	TO	O	20	VMOD	O
O	O	O	1252	1258	affect	affect	I-VP	VB	O	18	VMOD	O
O	O	O	1259	1272	proliferation	proliferation	B-NP	NN	O	23	NMOD	O
O	O	O	1273	1276	and	and	I-NP	CC	O	23	NMOD	O
O	O	O	1277	1292	differentiation	differentiation	I-NP	NN	O	20	OBJ	O
O	O	O	1293	1295	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	1296	1300	U937	U937	B-NP	NN	B-cell_line	26	NMOD	B-cell_line
O	O	O	1301	1306	cells	cell	I-NP	NNS	I-cell_line	24	PMOD	I-cell_line
O	O	O	1306	1307	.	.	O	.	O	6	P	O

O	O	O	1308	1313	Cells	Cell	B-NP	NNS	O	5	SUB	O
O	O	O	1314	1324	pretreated	pretreate	B-VP	VBN	O	1	NMOD	O
O	O	O	1325	1329	with	with	B-PP	IN	O	2	AMOD	O
O	O	O	1330	1338	dimaprit	dimaprit	B-NP	NN	O	3	PMOD	O
O	O	O	1339	1345	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	1346	1347	a	a	B-NP	DT	O	7	NMOD	O
O	O	O	1348	1356	decrease	decrease	I-NP	NN	O	5	OBJ	O
O	O	O	1357	1359	in	in	B-PP	IN	O	7	NMOD	O
O	O	O	1360	1363	the	the	B-NP	DT	O	11	NMOD	O
T24	B-Entity	B-Entity	1364	1368	cAMP	cAMP	I-NP	NN	O	11	NMOD	O
O	O	O	1369	1377	response	response	I-NP	NN	O	8	PMOD	O
O	O	O	1378	1380	to	to	B-PP	TO	O	11	NMOD	O
O	O	O	1381	1391	subsequent	subsequent	B-NP	JJ	O	14	NMOD	O
O	O	O	1392	1400	addition	addition	I-NP	NN	O	12	PMOD	O
O	O	O	1401	1403	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	1404	1406	H2	H2	B-NP	NN	O	17	NMOD	O
O	O	O	1407	1415	agonists	agonist	I-NP	NNS	O	15	PMOD	O
O	O	O	1415	1416	,	,	O	,	O	5	P	O
O	O	O	1417	1424	whereas	whereas	O	IN	O	5	VMOD	O
O	O	O	1425	1428	the	the	B-NP	DT	O	22	NMOD	O
T25	B-Entity	B-Entity	1429	1433	cAMP	cAMP	I-NP	NN	O	22	NMOD	O
O	O	O	1434	1442	response	response	I-NP	NN	O	26	SUB	O
O	O	O	1443	1445	to	to	B-PP	TO	O	22	NMOD	O
O	O	O	1446	1459	prostaglandin	prostaglandin	B-NP	NN	O	25	NMOD	O
O	O	O	1460	1462	E2	E2	I-NP	NN	O	23	PMOD	O
O	O	O	1463	1471	remained	remain	B-VP	VBD	O	19	SBAR	O
O	O	O	1472	1481	unaltered	unaltered	B-ADJP	JJ	O	26	PRD	O
O	O	O	1481	1482	.	.	O	.	O	5	P	O

O	O	O	1483	1487	This	This	B-NP	DT	O	3	NMOD	O
O	O	O	1488	1498	homologous	homologous	I-NP	JJ	O	3	NMOD	O
O	O	O	1499	1508	mechanism	mechanism	I-NP	NN	O	8	SUB	O
O	O	O	1509	1511	of	of	B-PP	IN	O	3	NMOD	O
T13	B-Protein	B-Protein	1512	1514	H2	H2	B-NP	NN	B-protein	6	NMOD	B-protein
T13	I-Protein	I-Protein	1515	1523	receptor	receptor	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	O	1524	1539	desensitization	desensitization	I-NP	NN	O	4	PMOD	O
O	O	O	1540	1543	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1544	1548	time	time	B-NP	NN	O	8	PRD	O
O	O	O	1549	1558	dependent	dependent	B-ADJP	JJ	O	9	AMOD	O
O	O	O	1558	1559	.	.	O	.	O	8	P	O

O	O	O	1560	1565	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1566	1573	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1574	1582	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	1583	1587	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1588	1597	histamine	histamine	B-NP	NN	O	6	SUB	O
O	O	O	1598	1607	activates	activate	B-VP	VBZ	O	4	SBAR	O
O	O	O	1608	1615	several	several	B-NP	JJ	O	8	NMOD	O
O	O	O	1616	1626	mechanisms	mechanism	I-NP	NNS	O	6	OBJ	O
O	O	O	1627	1635	involved	involve	B-VP	VBN	O	8	NMOD	O
O	O	O	1636	1638	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	1639	1642	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	1643	1652	induction	induction	I-NP	NN	O	10	PMOD	O
O	O	O	1653	1655	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	1656	1671	differentiation	differentiation	B-NP	NN	O	13	PMOD	O
O	O	O	1671	1672	,	,	O	,	O	8	P	O
O	O	O	1673	1677	such	such	B-PP	JJ	O	17	PMOD	O
O	O	O	1678	1680	as	as	I-PP	IN	O	8	NMOD	O
T26	B-Entity	B-Entity	1681	1685	cAMP	cAMP	B-NP	NN	O	23	NMOD	O
O	O	O	1686	1689	and	and	I-NP	CC	O	23	NMOD	O
T14	B-Protein	B-Protein	1690	1691	c	c	I-NP	NN	O	23	NMOD	O
T14	I-Protein	I-Protein	1691	1692	-	-	B-NP	HYPH	O	23	NMOD	O
T14	I-Protein	I-Protein	1692	1695	fos	fos	I-NP	NN	O	23	NMOD	O
O	O	O	1696	1706	production	production	I-NP	NN	O	17	PMOD	O
O	O	O	1706	1707	,	,	O	,	O	6	P	O
O	O	O	1708	1711	but	but	O	CC	O	6	VMOD	O
O	O	O	1712	1717	fails	fail	B-VP	VBZ	O	6	VMOD	O
O	O	O	1718	1720	to	to	I-VP	TO	O	28	VMOD	O
O	O	O	1721	1728	promote	promote	I-VP	VB	O	26	VMOD	O
O	O	O	1729	1744	differentiation	differentiation	B-NP	NN	O	28	OBJ	O
O	O	O	1745	1747	of	of	B-PP	IN	O	29	NMOD	O
O	O	O	1748	1752	U937	U937	B-NP	NN	B-cell_line	32	NMOD	B-cell_line
O	O	O	1753	1758	cells	cell	I-NP	NNS	I-cell_line	30	PMOD	I-cell_line
O	O	O	1758	1759	,	,	O	,	O	26	P	O
O	O	O	1760	1770	apparently	apparently	B-ADVP	RB	O	26	VMOD	O
O	O	O	1771	1774	due	due	B-PP	JJ	O	34	AMOD	O
O	O	O	1775	1777	to	to	B-PP	TO	O	34	AMOD	O
O	O	O	1778	1781	the	the	B-NP	DT	O	39	NMOD	O
O	O	O	1782	1787	rapid	rapid	I-NP	JJ	O	39	NMOD	O
O	O	O	1788	1803	desensitization	desensitization	I-NP	NN	O	36	PMOD	O
O	O	O	1804	1806	of	of	B-PP	IN	O	39	NMOD	O
T15	B-Protein	B-Protein	1807	1809	H2	H2	B-NP	NN	B-protein	42	NMOD	B-protein
T15	I-Protein	I-Protein	1810	1819	receptors	receptor	I-NP	NNS	I-protein	40	PMOD	I-protein
O	O	O	1819	1820	.	.	O	.	O	3	P	O
